Monday, October 26, 2026 · Daily editionET --:--:--

Finished

The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.

NCT05788133 · IRCCS Centro Neurolesi Bonino Pulejo · Updated 28 March 2023

What is being tested
treatment and screening by neuropsychological tests on humanoid robot
For
Neurodegenerative Diseases; Stroke
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 85 years. About 65 people. The full rules are on the registry page.
Where
Italy
When
Starts or started 28 Sept 2022, ends 31 Dec 2022. Registered 28 March 2023.
Results
None posted yet.

In the researchers' words

The role of humanoid robot in neuropsychological assessment and conducting cognitive training in patients with dementia and severe brain injury" Objectives Use of robotic solutions to carry out diagnostic and rehabilitation intervention in order to recover cognitive and relational performance of patients with dementia and severe brain injury. Study Design. Observational Materials and Methods. Eighty subjects (25 with mild-moderate dementia and 25 patients with severe brain injury) will be enrolled. Patients will undergo neurological examination with collection of all medical history and information on current clinical condition. After that, they will undergo administration of neuropsychological tests via humanoid robot and two months of cognitive rehabilitation sessions. Inclusion criteria * Over 18 years of age; * Patients with a moderately impaired cognitive profile; * Written consent from the legal guardian or the patient himself/herself. Exclusion criteria. * Patients with language comprehension deficits; * Patients with disorders of consciousness; * Patients who are unable to provide a localized, context-appropriate response; and All eligible patients will undergo cognitive assessment using the robot at the time of enrollment (T0), and after 2 months of rehabilitation treatment (T1) Translated with www.DeepL.com/Translator (free version)
ClinicalTrials.gov, NCT05788133

Sites

  • IRCCS Centro Neurolesi "Bonino-Pulejo"Messina, Italy